Cardinal Health (CAH) Suspends Production and Sales of its Alaris SE Infusion Pump After Units Were Seized By the FDA
Tweet Send to a Friend
Cardinal Health (NYSE: CAH) has suspended production, sales, repairs and installations of its Alaris SE infusion pump after approximately 1,300 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
